Background: Using differential display (DD), we discovered a new member of the serine protease family of protein-cleaving enzymes, named protease M. The gene is most closely related by sequence to the kallikreins, to prostate-specific antigen (PSA), and to trypsin. The diagnostic use of PSA in prostate cancer suggested that a related molecule might be a predictor for breast or ovarian cancer. This, in turn, led to studies designed to char-
INTRODUCTION
Serine proteases are protein-cleaving enzymes that contain a serine residue in their active sites and which play important roles in diverse phys-tigene family in rodents, although only three members of this family, hKLK1, hKLK2, and hKLK3, are known in humans. These three genes encode the proteins pancreatic/renal kallikrein (hK1), glandular kallikrein (hK2), and prostate-specific antigen (PSA; hK3), respectively (2) .
The hKl protein is secreted from pancreas, kidney, and salivary glands (3) , and is the only member of the family having true kallikrein activity. Its major function is the generation of kinins from kininogens and the regulation of blood pressure (1) . The hK2 protein has yet to be detected in human tissue or fluids, but its sequence has been inferred from a genomic clone (4), as well as cDNA clones isolated from prostate libraries (5) . hK2 expression is specific for prostate and is regulated by androgens (5) . PSA is produced predominantly in males by prostate epithelial cells and is secreted into the seminal fluid, where it serves to degrade the gel-like seminogelin protein and increase sperm motility (6, 7) . Although PSA is produced at higher levels in normal than in malignant prostate tissue, a defect in the malignant tissues ultimately results in the leakage of PSA into the bloodstream (8) . This is the basis of the use of PSA as a circulating tumor marker for prostate cancer.
Here, we describe the isolation by differential display (9-11) of a novel member of the serine protease family which is most homologous to trypsin and members of the kallikrein family. This novel protein, which we have named protease M, is down-regulated in metastatic breast cancer lines but strongly expressed at the mRNA level in some primary breast cancer cell lines and in ovarian cancer tissues and tumor cell lines.
MATERIALS AND METHODS

Mammary Cell Strains and Lines
Normal human mammary epithelial cell strains (70N and 76N) were derived from reduction mammoplasties in this laboratory as described (12) . Primary (21PT, 21NT) and metastatic (2 1MT-1, 2 1MT-2) tumor lines were established in this lab from a single patient as described (12, 13) . Human in DFCI-I media (12) and harvested at approximately 70% confluence for RNA isolation.
Prostate Cell Lines Normal, immortalized prostate epithelial cell lines: CF3 (HPV immortalized), CF91 (SV40 immortalized), and MLC (SV40 immortalized) were provided by Dr. Johng Rhim and were cultured in KGM medium (DIFCO, Detroit, MI, U.S.A.). The tumor cell lines DU145, LNCaP, and PC3 (ATCC) were grown in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetal calf serum (FCS, Hyclone, Logan, UT, U.S.A.).
Ovarian Cell Cultures and Tissues
The primary human ovarian surface epithelial cell cultures (HOSE 10/11, 16, and 21) were established from the ovarian surface epithelium as described (14) . Immortalized ovarian surface epithelial cells (HOSE6.3E6E7) were obtained by infecting the HOSE cells with a replication-defective retrovirus construct, LXSN16E6E7, as described (14) . The eight ovarian carcinoma cell lines used for this comparative study include DOV13, OVCA420, OVCA429, OVCA432, and OVCA433, which were established in the laboratory of Gynecologic Oncology; CAOV3 and SKOV3, which were purchased from ATCC; and OVCA3, which was obtained from the National Cancer Institute (Frederick, MD, U.S.A.).
Ovarian tumors obtained (15) include 6 borderline ovarian tumors (354A, 373A, 395A, 405A, 466A, and 469A); 20 stage 11/IV high grade invasive ovarian adenocarcinomas from the primary ovarian site; 2 metastatic adenocarcinoma from colon primary tumors (327A, 339A); and 3 normal ovaries (366N, 379N, and 465N).
Differential Display of mRNA Total cell RNAs (50 j,g) from 21PT and 21MT-1 were treated with DNAaseI (Worthington DPRF, Freehold, NJ, U.S.A.) in the presence of RNAasin ribonuclease inhibitor (Promega, Madison, WI, U.S.A.) to remove residual DNA contamination, as described elsewhere (11) . Differential display of the mRNA was performed as described (9, 10) . Basically, the RNAs were reverse transcribed using the 3'-anchored primer T12MG (where M is a mixture of A, G, or C). The resultant cDNAs were then polymerase chain reaction (PCR) amplified in the presence of 35S-dATP using T12MG and the arbitrary primer OPAl (CAGGCCCTTC) and run in adjacent lanes on a 6% sequencing gel. Differentially displayed bands were recovered from the dried gel, reamplified by PCR, 32P-labeled by the oligo method (16) (17) . Protein alignment with related proteins was performed on GCG using the Pileup, Distances, and Prettyplot programs.
Northern Analysis Total cell RNA was isolated by the guanidinium isothiocyanate/cesium chloride method and analyzed on Northern blots as described (18) . 36B4 (19) , a ribosomal protein whose message is constant under a variety of conditions, was used to normalize the blots. Densitometric analysis of autoradiographs was performed with an imaging densitomer (Biorad GS-700) using the Molecular Analyst software.
Mapping of the Protease M Gene A panel of 24 (23, 24) . For production of protease M, Spodoptera frugiperda (cell line SF9) was infected with amplified recombinant virus to obtain nearly 100% infection as gauged by enlarged cells. Ninety-six hours postinfection, cells were harvested and lysed by sonication in mammalian lysis buffer, adjusted to 500 mM NaCl and rocked for 1 hr at 4°C. All subsequent purifications were done at 40C.
The lysate was adjusted to 125 mM NaCl, loaded onto p-aminobenzamidine agarose (Sigma A7155, St. Louis, MO, U.S.A.), washed with loading buffer, and eluted with 25 mM NaPO4, 0.02% NaN3, 500 mM NaCl, 10 mM benzamidine, pH 6 .0. The eluted fractions were loaded onto concanavalin A agarose (Sigma C8402) by rocking for 1 hr, washed with 25 mM NaPO4, 0.02% NaN3, 500 mM NaCl, pH 6.0, and eluted in wash buffer containing 10% methyl-a-Dmannopyranoside (Sigma M6882). (106) were plated in five P100 dishes in Alpha + 5 % FCS. After 14 days of selection in media containing 1 mg/ml G418, the transfected clones were refed with media containing 0.5 mg/ml G418 for an additional week. Clones were picked in cloning cylinders, expanded, and maintained in Alpha + 5% FCS containing 0.5 mg/ml G418.
RESULTS
Differential Display
Total RNA from a primary breast cancer cell line (21 PT) was compared with that from a metastatic breast cancer cell line from the same patient (21 MT-1) by differential display (DD). Approximately 100 bands appeared for each primer pair tested, and on average two to three bands were differentially expressed. One of the bands The postulated protein sequence was compared with the four most closely related proteins using the Pileup and Distances programs, and the comparison was displayed by the Prettyplot program (Fig. 3) . Glandular kallikrein 2 (4,5) has 44% exact matches and 48% matches with conservative changes. Trypsin I (27) 19 (data not shown). There were no discordancies for localization to chromosome 19. To sublocalize the protease M locus, two-color FISH was carried out, using the genomic clone AIG3-1 as a probe. A total of 22 cells were analyzed. Fluorescent signals on one or both chromatids were found in the telomeric region of 19q in 15 metaphases spreads (Fig. 4) Figure 5A shows the results of Northern blots of mammary cell lines and strains. The two normal cells strains shown (76N and 70N) and another normal cell strain (81N) not shown expressed the 1.7-kb protease M message at low levels. Two primary tumor lines (21 PT and 21 NT) as well as one metastatic line from the same patient (21 MT-2) expressed high levels of message (approximately 20-to 100-fold higher than the normal strains). The most metastatic cell line from the same patient (21 MT-1), however, expressed low levels of RNA (Fig. LA) Ten micrograms of total cell RNA isolated from ovarian tissue was blotted, hybridized to protease M probe (as in Fig. 4 (Fig. 7) . While the message was not detected in heart, placenta, lung, liver, or skeletal muscle, high levels of message were detected in brain, kidney, and pancreas. The message detected in brain and kidney was 1.7 Fig. 4 ). The blot was exposed to X-ray film for 2 days. kD, while the amino acid sequence predicts a protein of about 27 kD. The potential glycosylation site at (134Asn-Thr-Thr' 36) might explain this size discrepancy. Table 1 shows that the RNA levels for the serine protease are not always correlated with the protein levels. While the primary tumor cell lines (21NT and 21PT) have 20 to 100 times more protease M mRNA than normal cell strains (70N, 76N, and 81N) , the protein detected on Western blots is equal to or somewhat lower in the primary tumor cell lines than in the normal cell strains.
Production of Polyclonal Antibody and Its
The antipeptide polyclonal protease M antibody has been used successfully in Western blots but does not seem to work in cellular immunofluorescence studies in which the antibody has given a high background with MDA-MB-435 cells, which do not express the protease M message.
Production of Recombinant Protein
Extensive efforts were made to produce recombinant protein for further study of the protease. As discussed below, production neither in E. coli as a GST-fusion protein nor in baculovirus as a pure protein was successful in providing more than minimal amounts of the protease. As a result, the products that were recovered were used primarily to verify the specificity of the antibody preparations.
In a further effort to obtain recombinant protein, transfectants were produced expressing protease M in the mammary tumor cell line MDA-MB-435. Transfectants were screened initially for protein production and, as shown below, the results demonstrated that only 5 of the 76 transfectants produced any protein and this at low levels.
Production of GST Fusion Protein
The expected 52-kD GST/protease M fusion protein was purified and yielded approximately 600 ,ug of fusion protein per 500 (39) . Physical mapping of this region has revealed that all three kallikrein genes are clustered within a 60-kb region and that the order is KLK1-PSA-KLK2 (40) . Our mapping data suggest that protease M may also be part of this gene cluster and that all four genes may have originated from a single ancestral precursor gene. Trypsin 1 (TRY1) and other more distantly related serine proteases, such as granzyme B (14ql1.2), cathepsin G (14ql1.2), coagulation factor VII (13q34), and protein C (2q13-q2 1), however, are all on other chromosomes, indicating that during evolution this gene cluster has been split up to several human chromosomes. Interestingly, chromosome band 19q1 3 is nonrandomly rearranged in a variety of human solid tumors, including pancreatic carcinomas, astrocytomas (grades III and IV), hemangiopericytomas, ovarian cancers, and thyroid tumors (41) . Whether any of these rearrangements affect protease M remains to be determined.
Protease M mRNA was expressed in normal breast and prostate cell strains but not in cell lines derived from metastatic tumors. The basis for this down-regulation is not known; however, since Southern blots show that the gene is neither lost nor grossly rearranged in breast tumor cell lines (data not shown), it may be transcriptional. While protease M mRNA was expressed in normal human brain, kidney, and pancreatic tissue, it was absent in heart, placenta, lung, liver, and skeletal muscle. This expression pattern resembles that of the kallikrein HKLK1 (3). In contrast, PSA is expressed primarily in the prostrate, though low levels have recently been detected in breast tissue (42) . We The protease M protein was detected in lysates of normal breast epithelial cell lines, but not in breast metastatic cell lines, and correlated with the mRNA expression levels. In the primary breast tumor cell line 2 1PT, however, very high mRNA levels were observed, though the protein level was low. This lack of correlation of mRNA and protein levels was also observed in MDA-MB-435 cells that were transfected with a protease M expression construct. Although many of the tranfectants expressed high levels of the mRNA, the protein was absent or barely detectable. These observations suggest that the expression of protease M is regulated both at the transcriptional and translational level. Whether the low protein levels are due to inefficient translation or rapid degradation of the translated protein is not known. Pulse-chase labeling experiments, followed by immunoprecipitation and Western blot analysis of protease M might elucidate the mechanism of translational down-regulation.
In breast, while the primary tumor cell lines (21 NT and 21 PT) expressed high levels of protease M message, another primary tumor cell line (BT474) did not express this message. When breast tissue samples were examined, two of the four primary tumor biopsies produced high levels of protease M message, whereas samples from normal adjacent tissue or reduction mammoplasties produced lower levels of the message (data not shown). Therefore, high protease M mRNA might serve as a marker for a subset of primary tumors. This subset of primary tumors could be distinguished from normal tissue by the higher levels of protease M mRNA. Protease M mRNA was expressed in the majority of primary ovarian tumor cell lines and tissues, but not in borderline ovarian tumor tissue, normal cell lines, or normal tissues.
These observations suggest that protease M might be useful as a diagnostic marker for primary epithelial carcinomas. Furthermore, the close sequence relatedness to trypsin and the presence of a signal peptide in the N terminus raise the possibility that the protein may have valuable medical applications.
